PS1024 IMPACT OF MINIMAL RESIDUAL DISEASE AND COMPLETE REMISSION (CR)/CR WITH PARTIAL HEMATOLOGIC RECOVERY ON SURVIVAL AFTER GILTERITINIB THERAPY IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY AML.

M. Levis, A. Perl, J. Altman, J. Cortes, C. Smith, M. Baer, D. Claxton, J. Jurcic, E. Ritchie, S. Strickland, R. Tibes, J. Hill, M. Rosales, E. Bahceci. PS1024 IMPACT OF MINIMAL RESIDUAL DISEASE AND COMPLETE REMISSION (CR)/CR WITH PARTIAL HEMATOLOGIC RECOVERY ON SURVIVAL AFTER GILTERITINIB THERAPY IN PATIENTS WITH FLT3-MUTATED RELAPSED/REFRACTORY AML. HemaSphere. 2019 Jun 30; 3(S1):461.

2019
https://researcherprofiles.org/profile/513920720

M. Levis, A. Perl, J. Altman, J. Cortes, C. Smith, M. Baer, D. Claxton, J. Jurcic, E. Ritchie, S. Strickland, R. Tibes, J. Hill, M. Rosales, E. Bahceci